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Abstract 
 
Aims: Type 2 diabetes (T2DM) is a growing burden among all countries including Pakistan, with 
medication adherence very important. However, little is known about medication adherence in 
Pakistan and potential predictors among T2DM patients to provide future guidance. This needs to 
be addressed. Consequently, the present study sought to assess medication adherence among type 
2 diabetic patients in Quetta city, Pakistan.  Methods: Questionnaire based, descriptive study 
among 300 Pakistani patients attending public and private hospitals aged 18 years and above, 
having a confirmed diagnosis of T2DM, without additional co-morbidities were targeted. 
Descriptive statistics were used to describe demographic and disease characteristics. The 
association between socio-demographic data and study variables was compared through Man 
Whitney / Kruskal Wallis test (where applicable). The factors that were significantly associated 
with medication adherence were further assessed by logistic regression analysis. Results: 55.6% 
of patients had high adherence although overall patients reported moderate adherence. Age, 
gender, education, diabetes-related knowledge and treatment satisfaction were significantly 
associated with medication adherence. Older males with only primary education and with poor 
diabetes-related knowledge had the lowest adherence. Conclusions: This study presents a model 
that is associated with medication adherence among T2DM patients, with disease-related 
knowledge as a significant predictor of likely adherence. Results of the current study revealed that 
improved diabetes related knowledge plays a significant role in improving medication adherence. 
Healthcare practitioners and the system should formalize and acknowledge patient education as a 
key component to treat patients with T2DM. This should include a greater role for pharmacists 
and other professionals. 
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Introduction 
 
Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia due to defects in 
insulin secretion, insulin action or both. Type 2 Diabetes Mellitus (T2DM) accounts for 
approximately 90% of all DM patients.[1] Persistent hyperglycemia results in micro and macro-
vascular complications, which together with their prevalence, results in DM being the seventh 
leading cause of death worldwide.[2]According to the International Diabetes Federation, currently 
415 million people world-wide suffer from diabetes. This figure is expected to increase to 642 
million by 2040[3], driven principally by a 69% increase in diabetes prevalence in developing 
countries.[4] Furthermore, mortality rates as high as 80% of the population due to non-
communicable disease (NCDs) have been reported among developing countries.[5] 
Unfortunately, the prevention and management of T2DM in low-resource settings are currently 
compromised by the socioeconomic situation[5]. This  is a concern as the disease is manageable 
including pharmacotherapy with oral hypoglycemic agents, insulin or both.[6] Adherence to 
medicines is critical to help managing patients with T2DM, with the World Health Organization 
(WHO) defining adherence as the degree of patients¶ medication taking behaviour, executing 
lifestyle changes, and following a diet plan, corresponding with agreed recommendations from 
the health care provider.[7]  In view f concerns with generally poor adherence to medicines, 
improving poor adherence rates in patients with T2DM with  existing medicines is currently seen 
as more beneficial to health care systems compared with developing new medical treatments.[8]  
 
Non-adherence of medicines in patients with T2DM arises from complex treatment regimens 
including multiple medications and self-care activities such as diet, exercise, foot care and regular 
glucose monitoring. Consequently, indicators of medication adherence are a valuable source for 
physicians and other professions to identify patients who are not responding to current regimens 
and need to improve their adherence rates.[9] Psychological problems, particularly depression, side-
effects of medication, presence of barriers to care, missed appointments and high patient co-
payments have all been reported as predictors of non-adherence.[10-14] 
 
Pakistan is currently ranked seventh in the world regarding the burden of T2DM,[15] with a current 
incidence varying from 7.6 to 11% of the population and growing.[16-18] However to date, 
medication adherence has not been seen as a major concern among health care providers in 
Pakistan.[19] This may be because little information is currently available regarding adherence rates 
among these patients, although what information is available suggests poor medication adherence 
in practice.[20-22] We would like to add to this knowledge by looking specifically at potential key 
predictors of medication adherence as a starting point for developing future initiatives in Pakistan. 
Consequently, the objectives of this paper are to review current adherence to medicines among 
T2DM patients in Pakistan and possible predictors of poor adherence. Subsequently use the 
findings to suggest potential future initiatives that could be introduced to improve adherence rates 
should this be a concern given the growing prevalence of T2DM in Pakistan and the subsequent 
impact on morbidity, mortality and costs if not adequately addressed. 
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Subjects, Materials and Methods 
 
Study design, inclusion criteria and settings  
The study was designed as a questionnaire-based descriptive analysis. Pakistani nationals aged 18 
years and above, having a confirmed diagnosis of T2DM, without additional co-morbidities, were 
targeted for the study. A diagnosis of diabetes including HbA1c levels and other disease related 
information was taken from medical records. Having a familiarity of Urdu (the official language 
of Pakistan) was also important for taking part in the study. The study was initiated in October 
2015 and lasted until March 2016. T2DM patients from both public (Sandamen Provisional 
Hospital and Bolan Medical Complex Hospital) and private hospitals (Alkahir Hospital, Alshafi 
Hospital and Sajid Hospital) located in Quetta city were approached by the principal investigator 
(QI) for data collection at the outpatient departments of the respective hospitals. This city was 
chosen as being representative of Pakistan. Both public and private hospitals were included to 
make sure a representative sample of patients were included, with T2DM patients typically treated 
in out-patient clinics. Currently in Pakistan, patients attending private facilities pay 100% out of 
pocket.  There is currently mixed payments in public facilities. The consultation is free in public 
institutes. However, only a limited number of medicines are available free to patients and they 
have to buy the rest out of pocket. 
 
Sampling criteria 
A prevalence based sampling method was used to calculate the minimum sample required for this 
study,[23] with a prevalence of 11% taken from reported studies.[24] However to minimize potential 
bias in sampling, a cumulative double design was added to the sampling initial frame and 
respondents were approached until we reached 300 for this study.[24] 
 
Study variables and data collection 
The study drew its frame work from the extensive literature on this subject [25-29]. The first author 
administered all the questionnaires and was solely involved in the data collection process. In 
addition to the demographics, diabetes-related knowledge and treatment satisfaction were taken as 
independent variables affecting medication adherence in the regression model. For prescribed 
medications, the medications that were prescribed for T2DM were taken into consideration. The 
above mentioned variables were assessed via validated questionnaires and permission was taken 
from the developers prior to data collection. 
 
Assessment of medication adherence 
The validated Drug Attitude Inventory (DAI-10) questionnaire in Urdu (National language of 
Pakistan) was used for the assessment of medication adherence.[25] DAI-10 is a generalized 
adherence measure consisting of ten questions that assess treatment adherence to all therapeutic 
regimens. Responses consist of yes or no, and scores range from 10 to ±10. Patients with scores 6-
10 were reported as adherent, 0-5 as moderate adherent and those in the negative ranges as non-
adherent[25].  DAI-10 is frequently used for assessment of medication adherence and is previously 
being used in the healthcare setting of Pakistan.[30] 
 
Assessment of diabetes-related knowledge 
The validated Urdu version of Michigan Diabetes Knowledge Test (MDKT) was used for the 
assessment of diabetes-related knowledge.[31] The MDKT was scored as zero for incorrect response 
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and one for a correct response consequently, knowledge scores ranged from 0-14. The range of 
knowledge score was categorized in three different ways (poor knowledge < 7, average knowledge 
7-11 and good knowledge > 11)[32]. 
 
Assessment of treatment satisfaction 
Treatment VDWLVIDFWLRQZDVEDVHGRQ WKH VXEMHFWLYH DVVHVVPHQWRI7'0SDWLHQWV¶ H[SHULHQFHV
towards healthcare professionals and the available facilities. The patients were given options to 
VWDWHWKHOHYHORIVDWLVIDFWLRQDVµVDWLVILHGEHLQJQHXtUDORUGLVVDWLVILHG¶ 
 
Other patient variables 
 
2WKHUYDULDEOHVVXFKDVSDWLHQWV¶HGXFDWLRQRFFXSDWLRQLQFRPHORFDOLW\GXUDWLRQRIWKHGLVHDVH
and family history of diabetes were asked in the questionnaire to add to the information contained 
in the SDWLHQWV¶QRWHV 
 
Ethical approval 
Institutional Review Board, Faculty of Pharmacy, University of Sargodha, Pakistan approved the 
study (22-2015/PREC/FOP/UOS). Additionally, permission to conduct the study was taken from 
the medical superintendent of the respective institutes. Written consent was also taken from the 
patients prior to data collection. The patients were informed about the research initiatives, 
confidentiality of their responses and their right to withdraw from the study with no penalty or 
effects on their treatment. 
 
Statistical analysis 
The KS test was used for normality analysis and non-parametric test were used accordingly.  
 
Descriptive statistics were used to describe demographic and disease characteristics of the patients. 
Percentages and frequencies were used for the categorical variables, while means and standard 
deviations were calculated for the continuous variables. The characteristics of the whole sample, 
medication adherence scores and diabetes-related knowledge scores were presented.  
 
Medication adherence and diabetes-related knowledge were calculated using the criteria originated 
by the developers. The association between socio-demographic data and study variables was 
compared through Man Whitney / Kruskal Wallis  test (where applicable).  The factors that were 
significantly associated with medication adherence were further assessed by logistic regression 
analysis. The logistic regression analysis included parameters with p value < 0.05 in the Man 
Whitney / Kruskal Wallis test. The power of independently related parameters and predictive 
models were expressed as odds ratio (OR) with 95% confidence intervals (CI). SPSS v. 20.0 was 
used for data analysis and results for all analyses were considered statistically significant at p<0.05. 
 
We did not break the patients down in those attending private or public facilities as the main 
difference was whether the consultation fee was free or not. However, we did break the patients 
down into key factors including occupation and income levels. 
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Results 
 
The study was conducted from October, 2015 to March, 2016. A total of 1520 patients were treated 
during the recruitment period. However, only 330 subsequently fulfilled the inclusion criteria. 
Three hundred T2DM patients were finally incorporated in the study as the remaining patients 
subsequently declined to participate in the study. The description of socio-demographic variables 
and frequency distribution of the respondents are summarized in Table 1.   
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Table 1: Characteristics of the study respondents (n=300) 
Characteristics Frequency (n) Percentage (%) 
Age group (51.25±9.59) 
30-40 
41-50 
51-60 
> 60 
 
43 
120 
90 
47 
 
14.3 
40.0 
30.0 
15.7 
Gender 
Male 
Female 
 
180 
120 
 
60.0 
40.0 
Education 
Primary 
Middle 
Metric 
Intermediate 
Graduate 
Postgraduate 
 
92 
41 
69 
34 
21 
43 
 
30.7 
13.7 
23.0 
11.3 
7.0 
14.3 
Occupation 
Unemployed 
Government Employee 
Private Employee 
Businessman 
 
127 
84 
35 
54 
 
42.3 
28.0 
11.7 
18.0 
Income *(Pakistan Rupee) 
No Income 
< 5000 
5000-10000 
10001-15000 
>15000 
 
96 
64 
46 
13 
81 
 
32.0 
21.3 
15.3 
4.3 
27.0 
Locality 
Urban 
Rural 
 
112 
188 
 
37.3 
62.7 
Duration of disease (years) 
Less than 1 year 
1-3 years 
3-5 years 
More than 5 years 
 
54 
97 
58 
91 
 
18.0 
32.3 
19.3 
30.3 
Family history of diabetes 
Yes 
No 
 
166 
134 
 
55.3 
44.7 
Number of prescribed drugs 
1-3 
More than 3 
 
279 
21 
 
93.0 
7.0 
Overall, are you are satisfied with present treatment? 
Satisfied 
Neutral 
Dissatisfied 
 
182 
33 
85 
 
60.7 
11.0 
28.3 
7 
 
 
The mean age (SD) of the patients was 51.25 (9.59) years, with males (60%) dominating the cohort. Ninety-two (30.7%) patients had 
primary level of education with 42.3% currently unemployed. 55.3% had a family history of T2DM, with 62.7% residing in rural 
locations. Overall, 60.7%were satisfied with their present treatment and consultation (Table 1). 
 
Table 2 presents the level of diabetes-related knowledge in the current study respondents. Out of the 300 respondents, 210 (70.0%) were 
within the poor knowledge range, 83 (27.6%) moderate and only seven patients (2.3%) showed adequate general knowledge about 
T2DM. Poor knowledge using the MDKT-14 knowledge score was apparent in responses to questions relating to diet and disease related 
information. The mean knowledge score was 5.83 ±1.92, indicating generally poor diabetes-related knowledge among T2DM patients.  
 
Table 2:  Description of diabetes-related knowledge among the study participants 
Diabetes Knowledge items Frequency 
(n) 
Percent  
(%) 
True 
(n) 
False 
(n) 
The suitable diet for a diabetic is: 
The way most Pakistani people eat 
A healthy diet for most people 
Too high in carbohydrate for most people 
Too high in protein for most people 
 
171 
77 
28 
24 
 
57.0 
25.7 
9.3 
8.0 
72 228 
Which of the following is highest in carbohydrates? 
Baked chicken 
Cheese 
Baked potato 
Peanut butter 
 
130 
96 
57 
17 
 
43.3 
32.0 
19.0 
5.7 
54 246 
Which of the following is highest in fat? 
Low fat milk 
Orange juice 
Corn 
Honey 
 
146 
117 
20 
17 
 
48.7 
39.0 
6.7 
5.7 
134 166 
Which of the following is free food? 
Any unsweetened food 
Any dietetic food 
Any food that says sugar free on the label 
Any food that has less than 20 calories per serving 
 
59 
187 
26 
28 
 
19.7 
62.3 
8.7 
9.3 
27 273 
Glycosylated haemoglobin (Haemoglobin A1) is a test that is a measure of your average blood glucose level 
for the past: 
Day 
 
 
22 
 
 
7.3 
131 169 
8 
 
Week 
6-10 weeks 
6 months 
63 
118 
97 
21.0 
39.3 
32.3 
Which is the best method for testing blood glucose? 
Urine test 
Blood test 
Both are equally good 
 
37 
152 
111 
 
12.3 
50.7 
37.0 
144 156 
What effect does unsweetened fruit juice have on blood glucose? 
Lowers it 
Raises it 
Have no effect 
 
69 
133 
98 
 
23.0 
44.3 
32.7 
121 179 
Which should not be used to treat low blood glucose? 
3 hard candies 
½ cup orange juice 
1 cup diet soft drink 
1 cup skim milk 
 
144 
42 
87 
27 
 
48.0 
14.0 
29.0 
9.0 
87 213 
For a person in good control, what effect does exercise have on blood glucose? 
Raises it 
Lowers it 
Has no effect 
 
220 
54 
26 
 
73.3 
18.0 
8.7 
219 81 
Infection is likely to cause: 
An increase in blood glucose 
A decrease in blood glucose 
Has no change on blood glucose 
 
114 
85 
101 
 
38.0 
28.3 
33.7 
83 217 
The best way to take care of your feet is to: 
Look at and wash them each day 
Massage them with alcohol each day 
Soak them for one hour each day 
Buy shoes a size larger than usual 
 
133 
66 
77 
24 
 
44.3 
22.0 
25.7 
8.0 
145 155 
Eating food lower in fat decrease your risk for: 
Nerve disease 
Kidney disease 
Heart disease 
Eye disease 
 
115 
60 
113 
12 
 
38.3 
20.0 
37.7 
4.0 
113 186 
Numbness and tingling may be symptoms of: 
Kidney disease 
Nerve disease 
Eye disease 
Liver disease 
 
39 
178 
76 
7 
 
13.0 
59.3 
25.3 
2.3 
181 119 
Which of the following is usually not associated with diabetes?   229 71 
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Vision problem 
Kidney problem 
Nerve problem 
Lung problem 
23 
27 
30 
220 
7.7 
9.0 
10.0 
73.3 
 Knowledge was assessed by giving 1 to correct answer and 0 to the wrong answer. The scale measured knowledge from maximum 14 to minimum 0.  
Scores < 7 were taken as poor, 7 - 11 average, and >11 good knowledge of diabetes. Mean knowledge was 5.83 ±1.92 
 
Table 3 presents the level of adherence in the current study respondents using the DAI-10. Among all the participants, 22 (7.3%) were 
low-adherers, 111 (37.0%) were medium adherers and 167 (55.6%) were considered adherent to medication therapies. The mean 
adherence score was 4.94 ± 2.72, indicating moderate level of adherence in this cohort of T2DM patients using the DAI-10 methodology. 
 
Table 3: Description of medication adherence among the study participants 
Drug adherence item False  True  
n % n % 
For me the good things about medication outweigh the bad 177 59.0 123 41.0 
I feel uncomfortable on medication 221 73.7 79 26.3 
I take medications of my own choice 25 8.3 275 91.7 
Medications make me more relaxed 39 13.0 261 87.0 
Medication make me tired and sluggish 164 54.7 135 45.3 
I take medication only when I am sick 173 57.7 127 42.3 
I feel more normal on medication 17 5.7 283 94.3 
It is unnatural for my mind and body to be controlled by medications 163 54.3 137 45.7 
My thoughts are clearer on medication 23 7.7 277 92.3 
By staying on medications, I can prevent getting sick 20 6.7 280 93.3 
Adherence  was  assessed  by  giving  1  to  correct  answer  and  -1  to  the  wrong  answer.  The scale measured adherence from a maximum of 10 to a 
minimum of -10. Any negative score was rated as poor adherence, 0 - 5 as moderate adherence and 6 - 10 as good adherent. Mean adherence was 4.94 ± 2.72. 
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Table 4 presents the cross tabulation analysis between socio-demographics and study variables. Man Whitney / Kruskal Wallis test 
reported a significant association between age, gender (males), education, diabetes-related knowledge (p<0.05). Older males having 
primary education and with poor diabetes-related knowledge were identified as an influencing cohort through Bonferroni correction.    
 
No significant association was reported among other variables. 
 
Table 4: Association among socio-demographics and medication adherence 
 
 
Logistic regression analysis of the model was performed after entering the considered independent variables to assess potential 
associations. In the logistic analysis age, gender, education, diabetes-related knowledge and treatment satisfaction were included as 
study parameters. The created model showed a significant goodness of fit as the Omnibus Test of Model Coefficient was highly 
significant (Chi square =11.342, p = 0.001, df = 4). The knowledge score had a significant association (adjusted OR= 2.232, 95 % CI = 
1.345 ± 1.766, P < 0.001) with medication adherence. An increase in knowledge score of one point is associated with increase in good 
adherence by a factor of 2.232 provided other confounding factors are controlled. 
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Discussion 
 
The current study aimed to highlight the predictors of medication adherence in a T2DM population attending both public and private 
facilities in Pakistan. As the patients were targeted randomly, chances of bias were minimized to give additional strength to the study 
design and findings.  There appeared to be moderate adherence (Table 3), with diabetes-related knowledge appearing as a positive 
predictor of medication adherence (Table 4). This is encouraging as previous studies conducted in other parts of Pakistan reported poor 
medication adherence among diabetes patients.[19-21] Poor medication adherence has also been observed among diabetes patients in the 
South Asian region.[26-28] One possible reason for the differences seen between the various studies is the different methodologies used 
to assess medication adherence. The literature reports a number of direct and indirect adherence measures, but there currently appears 
no gold standard method.[29 Although different methods are advocated, a combination of measures could improve the accuracy in 
recording current medication adherence rates. Consequently, we believe it is wise in the future to use multiple medication adherence 
tools in order to obtain a better picture of current adherence rates among diabetic patients, which we attempted to undertake in this study. 
 
Diabetes-related knowledge was reported as a predicting factor of medication adherence in the current study (Table 4). Our findings are 
in line with others whereby diabetes-related knowledge was found to be a correlating factor influencing medication adherence,[27, 33, 
34]which is perhaps not surprising. However, developing countries are faced with limited resources, poor infrastructures and ill equipped 
healthcare system. Communicable diseases are generally more prevalent and less attention has typically been paid to the management 
of NCDs like T2DM in these countries. Additionally, when compared with communicable diseases, currently few policies have been 
designed and implemented at administrative levels to better manage NCDs such as T2DM.[35] However, this is changing, [5] with the 
WHO and others highlighting the importance of improved prevention and management of these patients including improving adherence 
rates with current medicines.[36] Against this,  in Pakistan, patients typically pay most of their healthcare costs out-of-pocket, and the 
choice of consulting a registered health care professional is generally the last option. Patients generally prefer to consult other sources, 
including traditional healers and alternative therapists, first before seeking professional care. The poor knowledge gained can shape 
future medication taking behaviour and management including patients with T2DM. Consequently, in order to change the medication 
taking behaviour of T2DM patients, dissemination of the right information at the communal level is needed so that patients can 
understand the benefits of consulting registered healthcare professionals and the potential harms related to illegal and unauthorized 
health care practices. The findings in this study further highlight the challenges involved given variable knowledge and variable 
medication adherence levels even among patients attending outpatient clinics in hospitals (Table 2 and 3). This can involve all key 
stakeholder groups, including potentially religious leaders and others[37].  
 
Ideally all oral medicines to treat patients with T2DM should be available free, including oral anti-diabetic medicines, medicines to 
control BP as well as statins given concerns with issues of co-payments, with commercial organisations believing they can supply such 
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medicines for US$1/ patient/ month/ medicine.[38, 39] This is a consideration for the future in Pakistan given its manufacturing base 
alongside suggestions to improve the quality of locally produced generics. [40 
 
Another issue for the authorities in Pakistan to consider is collaborative care, which is typically not practiced at healthcare institutions. 
Physicians currently have limited interaction with pharmacists while designing therapeutic regimens for their patients[41], and 
pharmacists face certain barriers with providing clinical services. Currently, hospital and other pharmacists in Pakistan do not typically 
provide education to patients.[42] As a result, diabetes patients in Pakistan may not always receive the required information to improve 
their medication adherence (Table 4). Consequently, a collaborative care approach is recommended with pharmacists and other 
healthcare professionals, including physicians and nurses working together and providing information to patients on the medicines they 
should take and the need to adhere to them. As a result, patients will become more empowered. This could include potentially Diabetes 
Nurse Educators in the future, with such initiatives  already happening in some countries[43-48] . This needs to be taken forward in 
Pakistan. Once patients are empowered with the right diabetes-related knowledge, medication taking behaviour can be improved (Table 
4) and the objectives of treatment attained. We will be following this up with further research and initiatives to improve the care of 
patients with T2DM in Pakistan. 
 
Alongside this, we will also be looking at ways to generally improve physician knowledge of medicines and their place in care since 
previous research has shown most physicians in Pakistan still rely on pharmaceutical companies for their source of information. [,49] 
Pharmacists and other professionals  can play a role in developing services such as independent advice through Drugs and Therapeutic 
Committees to enhance future medicine selection and use.[50-]  Future activities will also include researching potential ways to reduce 
patient reliance on traditional healers and alternative therapists, since without this care will continue to be sub-optimal. 
 
We are aware that our study included hospitals from only one city in Pakistan. However, we believe that our findings are robust in view 
of the number of patients involved and provide direction for the future. We will though be following this up with further research in 
other cities given the concerns that we identified. 
 
Conclusion 
 
Medication adherence among diabetes patients is a concern across countries including Pakistan. A distinctive feature of this study is that 
it focused T2DM patients without co morbidities that to the best of our knowledge is the first of its kind from Pakistan. Results of the 
current study revealed that improved diabetes related knowledge plays a significant role in improving medication adherence. Thus, it is 
suggested that improved knowledge of T2DM and its management can reshape medication taking behaviour, which in return will 
improve glycemic control and reduce the complications associated with T2DM. Healthcare systems should formalize and acknowledge 
patient education as a key component of therapeutic plans in order to improve future adherence rates. As a result, help reduce the 
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complications associated with T2DM and the subsequent impact on morbidity, mortality and costs. Pharmacists along with physicians 
and other professionals can play an increasing role to improve patient care in Pakistan through co-ordinated approaches, building on the 
success in other countries. This should become a goal in Pakistan along with initiatives to reduce patient co-payments. Without such 
initiatives, care of these patients will continue to be sub-optimal. 
 
Limitations 
The study was conducted based on a prevalence based approach. We believe that the sample is representative of the region but we 
acknowledge that a larger scale study across different regions in Pakistan is recommended to generalize the findings.    
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